MedWorm: Pharmaceuticals

Socorex Acura electro Pipettes – New Premium Comfort and Precision...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

A portfolio of electronic pipettes designed to make pipetting more versatile, simpler and safer than ever.(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9148226.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Find the best January Sales in the UK.

PortaFab Introduces New Cleanroom Wall System for Interior Walls

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Two inch thick wall system provides cost effective alternative to traditional modular cleanroom systems.(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/cleanroom/walls/prweb9146612.htm (Source: PRWeb: Medical Pharmaceuticals)

DermaVeratrol’s Anti-Aging Approach Affirmed by New CNN Beauty Study

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

As new CNN report unveils common beauty concerns among women of all ages, DermaVeratrol finds its emphasis on smooth, youthful skin affirmed.(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/DermaVeratrol/01/prweb9145905.htm (Source: PRWeb: Medical Pharmaceuticals)

Meridia Audience Response Conducts its 20,000th Live Event

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

On January 15th, 2012 Meridia Audience Response provided group polling and accreditation reporting for a National Medical Association. This event was Meridia’s 20,000th live event in its 42-year...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9145887.htm (Source: PRWeb: Medical Pharmaceuticals)

SeraCare Launches Five New Infectious Disease Panels Including First...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

SeraCare Life Sciences announced it has launched new infectious disease panels for HIV, HBV, HAV and CMV markers, and a first-of-its-kind performance panel for parvovirus B19, most commonly associated...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9142297.htm (Source: PRWeb: Medical Pharmaceuticals)

Rottenstein Law Group Alarmed by Further Manufacturing Improprieties...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, has...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9135576.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Healthcare Data Solutions Announces Accurate Prescriber Data...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The new partnership of Concur’s cloud- and mobile-based travel and expense management solution and Healthcare Data Solutions’ complete, accurate, relational and multi-dimensional data allows companies...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9132272.htm (Source: PRWeb: Medical Pharmaceuticals)

The Consumer Justice Foundation Alerts Public to Study Revealing...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.depakotebirthinjury.com and which is staffed by...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9152057.htm (Source: PRWeb: Medical Pharmaceuticals)

Judge Postpones Yasmin Trial: AttorneyOne.com Warns the Threat from...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Earlier this month, U.S. District Judge David Herndon in Illinois postponed the Jan. 9 trial of a lawsuit accusing Bayer, the company manufacturing Yasmin, of misleading women about the health risks...(PRWeb January 30, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9150955.htm (Source: PRWeb: Medical Pharmaceuticals)

Free Certification Training From CertSchool.com in the Latest...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Seeking to improve team collaboration and project results, companies are updating to Microsoft Project 2010’s new set of tools for project managers. CertSchool.com is presenting a free certification...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/microsoft/free-training/prweb9157565.htm (Source: PRWeb: Medical Pharmaceuticals)

BioSoteria Will Host A Generic Drugs Good Safety Practices Roundtable...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

BioSoteria announces the creation of a Roundtable for Safety Surveillance Practices in Generic Drug Companies.(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9155982.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Regulatory Affairs Professionals Society (RAPS) Launches Biennial...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Regulatory Affairs Professionals Society (RAPS) is again conducting its biennial research initiative on the regulatory profession, the RAPS Global Scope of Practice & Compensation Survey, and...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9155693.htm (Source: PRWeb: Medical Pharmaceuticals)

Designation of Certified Payments Professional Granted to Payment...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Electronic Transactions Association Designates David Bergert and Ron Barker of On-Line Strategies as CPPs(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/On-Line-Strategies/payment-consultants/prweb9154541.htm (Source: PRWeb: Medical Pharmaceuticals)

DDN Presents Cold Chain Management Solutions at Healthcare...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Larry Sweeney, COO of DDN, the largest privately-held provider of outsourced channel management and business services to the life science industry, will provide cold chain management solutions during...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9153786.htm (Source: PRWeb: Medical Pharmaceuticals)

China Pharma Market Development Examined in New Report Published at...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Where is the pharmaceutical market in China heading? How will governmental reform of the healthcare system affect the pharmaceutical industry? Answers to these critical questions and many more can be...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9153353.htm (Source: PRWeb: Medical Pharmaceuticals)

Clayton Sleep Institute Adds AASM Home Testing Accreditation

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

CSI continues national, regional leadership in sleep medicine(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9152498.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Acne Control Mask from End-Zit® - Fight Acne with a High...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

ABBE Laboratories best-selling END-ZIT® Acne Control Mask is now available in a convenient 2.5oz. squeezable tube. Use as a spot treatment or apply to the entire face, back or any problem area....(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9151702.htm (Source: PRWeb: Medical Pharmaceuticals)

Arch Enterprises Adds Industrial Chemical Catalysts to their List of...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Arch Enterprises offers platinum group metal (PGM) refining solutions for industries that have the need to recover platinum from industrial chemical catalysts.(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/catalyst/refining/prweb9151332.htm (Source: PRWeb: Medical Pharmaceuticals)

Rottenstein Law Group Hopes the FDA Reclassifies Vaginal Mesh as a...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Rottenstein Law Group, which represents clients with claims stemming from the adverse effects of vaginal mesh, hopes the FDA changes its classification of vaginal mesh from a Class II medical...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9150360.htm (Source: PRWeb: Medical Pharmaceuticals)

Altoona Regional Advances EMR Initiative with Electronic Forms on...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Access Intelligent Forms Suite, the world’s leading e-forms management system, eliminates paper forms inefficiency at three locations and also enhances patient safety with barcoded wristbands. Dynamic...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9149853.htm (Source: PRWeb: Medical Pharmaceuticals)

Infinata's BioPharm Clinical™ to Showcase Study Feasibility and...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Complimentary two-week free access available at the new biopharmclinical.com(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9148980.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Find the best January Sales in the UK.

DoctorDirectory Survey Finds Brand Name Drugs Pay the Price for...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Brand loyalty is nearly non-existent when it comes to physician prescribing behaviors in spite of reports of diminished performance from generic equivalents. 95% of prescribers surveyed report they...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9146579.htm (Source: PRWeb: Medical Pharmaceuticals)

BioConference Live Announces 2012 Virtual Event Schedule

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Free Virtual Events at http://www.BioConferenceLive.com focusing on the Clinical Diagnostics, Life Sciences, and Laboratory Animal Sciences Community(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9146126.htm (Source: PRWeb: Medical Pharmaceuticals)

PAINWeek 2012: Ready to Address the Epidemic of Chronic Pain

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Challenges cited in the 2011 Institute of Medicine (IOM) report and the recent NEJM article have made PAINWeek the largest US pain conference for frontline practitioners.(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9145505.htm (Source: PRWeb: Medical Pharmaceuticals)

Europe and Asia Continuing Medical Education Events Have Been...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. Imedex® develops high quality, scientific programming that...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9143356.htm (Source: PRWeb: Medical Pharmaceuticals)

Rottenstein Law Group Notes Report Suggesting Bone Density Retesting...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has read with keen interest a report suggesting that patients with normal...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9142859.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

The Consumer Justice Foundation Alerts Public to the Release of 2011...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.topamaxbirthinjury.com, hereby announces that...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9155349.htm (Source: PRWeb: Medical Pharmaceuticals)

Absorption Systems Expands In Vivo Drug and Medical Device Testing...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Preclinical contract research organization renovates facility, adding state-of-the-art technology and upgrading ocular testing services.(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9153045.htm (Source: PRWeb: Medical Pharmaceuticals)

US Drug Watchdog Expands Its Initiative For Women With A Femur...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The US Drug Watchdog says, "We are becoming increasing concerned that women, who have had a femur break, after using the osteoporosis drug called Fosamax are signing on with a law firms, that...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9147653.htm (Source: PRWeb: Medical Pharmaceuticals)

Oregon Teen Author Alexandra Gritta Raises $20,000 for Rescued PMU...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Sixteen-year-old Alexandra Gritta works to raise both funds and public awareness for horses forced to suffer at PMU (Pregnant Mare Urine) facilities in order to produce the hormone replacement therapy...(PRWeb January 31, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb8893365.htm (Source: PRWeb: Medical Pharmaceuticals)

NDCBlogger Chosen As An American Society for Quality "Influential...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

A social media initiative from ASQ entitled Influential Voices will feature Deborah Mackin, founder and Principal Performance Strategy Consultant at New Directions Consulting, as an ongoing quality...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9152301.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Proxy Life Sciences Holding to Test Virtual-Biopsy Technology for...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Proxy Life Science Holdings has established a multiyear collaboration with NutraClinical for the clinical evaluation of its Proxysome™ virtual biopsy technology. Proxysomes™ are commonly known as...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9150264.htm (Source: PRWeb: Medical Pharmaceuticals)

Over 900 Lawsuits Filed in Pinnacle Hip Replacement MDL

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Bernstein Liebhard LLP reports that DePuy Pinnacle hip replacement lawsuits filed in federal court are quickly mounting. Currently, there are over 900 DePuy Pinnacle hip replacement lawsuits pending...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/pinnacle-hip-replacement/consumer-injury-lawyers/prweb9160350.htm (Source: PRWeb: Medical Pharmaceuticals)

New Website Launched on Low Carb Bread Recipe

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Looking to get in shape and stay healthy? One visit to Low Carb Bread Recipe .org will change your life by showing you simple tips on how to lose weight.(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9158983.htm (Source: PRWeb: Medical Pharmaceuticals)

MedCallAssist to Display Mobile Medical Product Kits and 24/7 Medical...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

MedCallAssist, a company that provides hunters, travelers, truck drivers and others who spend time in remote areas of the world and who may need help with medical emergencies with telemedicine, hereby...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/telemedicine/medical-kits/prweb9155460.htm (Source: PRWeb: Medical Pharmaceuticals)

Rottenstein Law Group Learns of Zoloft Manufacturer's Motion to...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Rottenstein Law Group, which represents clients with claims stemming from the birth defects caused by the antidepressant Zoloft, has learned that Pfizer, Zoloft's manufacturer, has filed a...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9155258.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Canada Drugs Online Stocks Pirfenidone, the Preferred IPF Medication

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Canada Drugs Online has stocked up on popular IPF medication pirfenidone. Pirfenidone is used to treat ipdiopathic pulmonary fibrosis, a fatal disease that affects over 5 million people worldwide.(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/pirfenidone/canadadrugsonline/prweb9155255.htm (Source: PRWeb: Medical Pharmaceuticals)

Swisslog Lands First Rehabilitation Facility Order for MedRover™

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Rehabilitation facility in New Jersey to replace stationary medication cabinets with innovative mobile dispensing solution.(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/Bacharach/MedRover/prweb9154150.htm (Source: PRWeb: Medical Pharmaceuticals)

African Mango – NZ Stores Now Stocking Internationally Acclaimed...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

A new super supplement is now on sale in New Zealand – African Mango. NZ consumers can purchase the supplements (favoured by Hollywood’s elite and promoted on high-profile health TV shows) through...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9153049.htm (Source: PRWeb: Medical Pharmaceuticals)

Roboz Surgical Publishes Dumont Forceps Catalog

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Roboz Surgical has come out with a new catalog to help in choosing Dumont forceps.(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/dumont_forceps/catalog/prweb9152207.htm (Source: PRWeb: Medical Pharmaceuticals)

Veracity Insurance Solutions, LLC Purchases Stratus Insurance...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Stratus Insurance Services, Inc. has been purchased by Veracity Insurance Solutions, LLC, effective January 1, 2012. Veracity Insurance Solutions, LLC will be the name of the newly combined company...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/veracity/stratusins/prweb9152072.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Congressional Hearing on Reauthorization of User Fees: What It Means...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

California Healthcare Institute CEO provides testimony on user fees and future of biomedical innovation(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9156996.htm (Source: PRWeb: Medical Pharmaceuticals)

New Lawsuit Filed Blaming DVT on NuvaRing: AttorneyOne.com Provides...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

According to court documents, in a suit filed on Jan. 9 in the Eastern District of Texas, Sherman Division, no. 4:12-cv-00008, a Danton woman, Dawn Kregel, used the NuvaRing for just over a month in...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9156671.htm (Source: PRWeb: Medical Pharmaceuticals)

Corporate Whistle Blower Center Urges ER Physicians Or Hospital...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The Corporate Whistle Blower Center is urging Emergency Room Physicians, nursing managers, or hospital accounting, or coding staff to turn in their hospital for Medicare, or Medicaid fraud, if the...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9156050.htm (Source: PRWeb: Medical Pharmaceuticals)

Eclipse Therapeutics Appoints Hans Clevers, M.D., Ph.D., and Thomas...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Eclipse Therapeutics, Inc., a biotechnology company dedicated to the discovery and development of novel therapeutics that target cancer stem cells, announced today the appointments of Hans Clevers,...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9155733.htm (Source: PRWeb: Medical Pharmaceuticals)

US Drug Watchdog Dramatically Intensifies Its Efforts To Insure...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The US Drug Watchdog is warning diabetics, who used the diabetes drug called Actos, and then developed bladder cancer, to call them for the names, and contacts of the best possible national caliber...(PRWeb February 01, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9155285.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Norwich Expands Capabilities for Phase I-III Clinical Trials

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced an expansion at two research facilities in order to meet...(PRWeb February 02, 2012)Read the full story at http://www.prweb.com/releases/NorwichExpands/ClinicalResearch/prweb9160796.htm (Source: PRWeb: Medical Pharmaceuticals)

Start-Up Makes Its Mark in Drug and Device Regulatory Intelligence

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

New publisher, RegLink, provides innovative, user-friendly way to stay on top of “What’s New” around the world through cost-effective eweekly Updates with links to source documents.(PRWeb February 02, 2012)Read the full story at http://www.prweb.com/releases/reglinkdrugdevicebiologic/regulatoryglobal/prweb9159459.htm (Source: PRWeb: Medical Pharmaceuticals)

Superior Medical Solutions Now Offering Saliva Drug Test Kits

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

Superior Medical Solutions is now offering saliva drug test kits available on its online store. There are multiple options available, and all orders over $100 receive free shipping.(PRWeb February 02, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9144093.htm (Source: PRWeb: Medical Pharmaceuticals)

US Drug Watchdog Expands its Metal on Metal Defective Hip Implant...

PRWeb: Medical Pharmaceuticals — Fri, 03 Feb 2012 06:24:02 +0100

The US Drug Watchdog is expanding its defective hip implant victims initiative to include not just the recalled DePuy ASR hip implant, but all US citizens, who have what is called a metal-on-metal hip...(PRWeb February 02, 2012)Read the full story at http://www.prweb.com/releases/2012/2/prweb9161196.htm (Source: PRWeb: Medical Pharmaceuticals)

Turkal: Sinai decision will be made within 60 days

bizjournals.com Health Care:Pharmaceuticals headlines — Fri, 03 Feb 2012 06:21:37 +0100

A decision about the future of Aurora Sinai Medical Center in Milwaukee will be made within 60 days, according to Dr. Nick Turkal, president and chief executive officer of Aurora Health Care. Turkal sent out a letter to community members Thursday night saying the plan will fulfill Aurora's pledge to balance "sound clinical practice, patient and community needs and what we can afford as a single health care system among several serving Milwaukee." Sinai has lost $107 million over the last decade and is projected to lose another $30 million this year if nothing changes... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Do something really innovative in health: crowdsource problems, not (just) solutions

Forbes.com Healthcare News — Fri, 03 Feb 2012 06:01:38 +0100

Businesses exist to solve problems, right? Certainly, this is the heart of the classic entrepreneurial model: you become obsessed with a particular problem, and create a business to solve it. Example: eBay was created by Pierre Omidyar to solve a perceived problem with inefficient markets, and since its inception has generally focused on doing exactly this. (Source: Forbes.com Healthcare News)

SSRIs increase risk of falls, injuries for elderly patients with dementia

Drug Topics - Pharmacy News — Fri, 03 Feb 2012 05:00:00 +0100

Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are 3 times more likely to have a fall resulting in injury compared with those who don?t use SSRIs, according a study published online January 18 in the British Journal of Clinical Pharmacology. (Source: Drug Topics - Pharmacy News)

AstraZeneca chairman to stand for re-election

FT.com - Drugs and Healthcare — Fri, 03 Feb 2012 04:44:16 +0100

Louis Schweitzer will stand again after the group's failure to find a successor (Source: FT.com - Drugs and Healthcare)

Allergan expects strong European sales

FT.com - Drugs and Healthcare — Fri, 03 Feb 2012 04:44:16 +0100

The US maker of Botox is betting that its European business will see a lift as plastic surgeons shift away from lower cost breast implants (Source: FT.com - Drugs and Healthcare)

Study: Hospitals Overpay for Devices

WSJ.com: Health — Fri, 03 Feb 2012 03:41:42 +0100

Some hospitals pay thousands of dollars more than others for big-ticket medical devices such as defibrillators, and a portion of the higher costs could be passed on to Medicare. (Source: WSJ.com: Health)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Nonprofits' Backers Mobilize

WSJ.com: Health — Fri, 03 Feb 2012 03:10:56 +0100

The Susan G. Komen for the Cure breast-cancer charity grappled with the fallout from its decision to cut funding for Planned Parenthood affiliates, as both groups saw a surge in donations. (Source: WSJ.com: Health)

CMS Releases Details Of Proposed National Coverage For TAVR

Forbes.com Healthcare News — Fri, 03 Feb 2012 02:46:39 +0100

On Thursday the Centers for Medicare & Medicaid Services (CMS) released a memo containing details of its proposed Medicare coverage for TAVR (transcatheter aortic valve replacement). The memo is a response to a formal request for national coverage determination (NCD) from the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). The memo will be open for public comment until March 3, after which a final determination will be made. (Source: Forbes.com Healthcare News)

The Truth About Contraception, Obamacare And The Church

Forbes.com Healthcare News — Fri, 03 Feb 2012 01:45:58 +0100

Image by AFP/Getty Images via @daylife Much has been misunderstood about what the Affordable Care Act requires when it comes to religious institutions and contraception. Recently, the Catholic Church lashed out at the Obama Administration, including HSS Secretary Kathleen Sebelius, for handing down regulations that fail to exempt certain operations of the (Source: Forbes.com Healthcare News)

Can Greenway Medical Keep Up The Momentum After Its IPO?

Forbes.com Healthcare News — Fri, 03 Feb 2012 00:54:45 +0100

Greenway Medical Technologies, a seller of electronic health records, got off to a bumpy start when its bankers re-priced last minute its IPO downward to $10 a share from an original range of $11 to $13 a share. It closed today at $13, up 30%--valuing it at three times revenue, in line with competitors such as NextGen. (Source: Forbes.com Healthcare News)

Drug firm Indoco Remedies ties up with DSM pharma

The Economic Times Healthcare and Biotech News — Thu, 02 Feb 2012 23:49:47 +0100

Drug firm Indoco Remedies has entered into a marketing pact with DSM Pharmaceutical Products NV which will sell its products in Austria and other int'l mkts. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Breast Cancer Action donations surge after Komen-Planned Parenthood fiasco

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 23:32:25 +0100

Believe it or not, there is a beneficiary of the controversial decision by Susan G. Komen for the Cure to not continue funding breast cancer screening at Planned Parenthood centers. San Francisco-based Breast Cancer Action saw donations from its recent email alerts surge 30-fold from the average volume of click-throughs from the alerts, said spokeswoman Angela Wall. It sent out two alerts Wednesday about the change in Komen’s grant process, which Planned Parenthood has charged was based on pressure from antiabortion activists, and how the change affects Planned Parenthood... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Amazon supports same-sex marriage, following other area companies

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 23:14:11 +0100

Amazon is joining other local tech companies in backing a proposed state law to legalize same-sex marriages. In a statement, Seattle-based Amazon said the “spirit of these bills is consistent with our long-standing employment practices.” The statement, reported by The Seattle Times, comes a couple of weeks after Microsoft, RealNetworks and Concur said they were endorsing a move to legalize same-sex marriage in Washington. The state Senate passed legislation Wednesday that would legalize gay marriage in the state... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

U.C. Berkeley intellectual property has started 146 companies in 20 years

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 22:42:09 +0100

Intellectual property rights from the University of California, Berkeley, have been used to start 146 businesses in the last two decades. Some prolific professors have started plenty of companies -- chemist Richard Mathies, for example, has helped start 15 businesses, with five of them directly based on his laboratory’s breakthroughs. Mathies has 35 patented inventions, among them miniaturized “labs on a chip” -- an idea behind Affymetrix Inc. (NASDAQ: AFFX), which he helped found. Chiron Corp... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Bascom Palmer plans 547,000 square feet of expansions

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 22:27:13 +0100

The University of Miami’s Bascom Palmer Eye Institute has four expansion initiatives planned that total 547,475 square feet. The first initiative is to double the size of its 6,157-square-foot office in Plantation. By the fall of 2013, Bascom Palmer plans to add 21,318 square feet to its Palm Beach Gardens medical office – a nearly 50 percent increase in size. In Naples, Bascom Palmer is adding 1,283 square feet to its office in the next few months, which also represents a 50 percent increase... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

State Bank of Mysore files criminal complaint against Sterling Biotech

The Economic Times Healthcare and Biotech News — Thu, 02 Feb 2012 22:16:03 +0100

State Bank of Mysore has filed a criminal complaint against Sterling Biotech, and its six directors, for allegedly defaulting on repayments. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Fortis Healthcare mulls hiving off non-core business

The Economic Times Healthcare and Biotech News — Thu, 02 Feb 2012 22:11:00 +0100

Fortis Healthcare Ltd, the country's largest hospital company, plans to hive off its non-core business and related assets into a separate company. (Source: The Economic Times Healthcare and Biotech News)

Auxogyn raises $20M in Series A funds

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:56:52 +0100

Auxogyn Inc. said Thursday it has closed of the final tranche of its Series A funding. The private Menlo Park-based company is focused on advancing women's reproductive health and has raised $20 million to date. It specializes in a non-invasive early embryo viability assessment system called Eeva. According to a prepared statement, the initial tranche was placed in May 2010, and investors in the round include Menlo Park-based Kleiner Perkins Caufield & Byers, San Francisco-based TPG Biotech and Merck Serono Ventures, the strategic venture capital fund of Merck Serono, the division for biopharmaceuticals of German chemical and pharmaceutical company Merck KGaA... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Gilead Q4 profit up, but EPS miss analyst estimates

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:40:30 +0100

Gilead Sciences Inc.'s stock rose 0.16 percent to close at $49.31 per share on Thursday, but was trading more than 1 percent down after hours. The Foster City-based biopharmaceutical company (NASDAQ:GILD) reported net income for the fourth quarter of 2011 of $665.1 million, or 87 cents per diluted share, compared to $629.4 million, or 76 cents per diluted share for the fourth quarter of 2010. The company said fourth quarter revenue increased 10 percent to $2.20 billion, from $2 billion for the fourth quarter of 2010... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

St. Elizabeth denied NICU unit

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:28:49 +0100

St. Elizabeth Healthcare has been denied Kentucky approval to open an advanced neonatal intensive care unit. The hospital system applied in 2009 for the Level III NICU designation. But it failed to convince the Kentucky Cabinet for Health and Family Services the Kentucky needs the 12-bed service. A spokeswoman for the organization said St. Elizabeth is likely to appeal the decision. St. Elizabeth hoped to lure back the 990 Northern Kentucky women who leave the state to have their babies at Cincinnati Children’s Hospital Medical Center or elsewhere... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Affymax promotes Smith to VP, market access, commercial development

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:13:38 +0100

Affymax Inc. said Thursday it has promoted Cynthia Smith to vice president, market access and commercial development. Smith has been with the Palo Alto-based biopharmaceutical company (NASDAQ:AFFY) since 2008 as executive director, public policy, payer strategy, and operations. "Cynthia has made significant contributions to Affymax over the last three years, helping to build and provide leadership to Affymax's commercial organization, particularly as it relates to reimbursement and payer strategy," said Jeffrey Knapp, chief commercial officer of Affymax in a prepared statement... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Gray taps Elaine Crider to serve on UMC board

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:08:04 +0100

D.C. Mayor Vincent Gray has tapped Elaine Crider, an independent project management consultant from Ward 8, to join the United Medical Center board of directors. He has also asked Virgil McDonald to remain on the board for another term. D.C. Council must approve both appointments, which would run through 2014. If confirmed, Crider will replace Robin-Eve Jasper, the former director of the D.C. Department of Real Estate Services, who was first appointed to the board by then-Mayor Adrian Fenty shortly after the District seized the hospital in 2010... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Myriad's Prolaris(R) Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 21:05:00 +0100

SALT LAKE CITY, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled, "Validation of a panel of cell-cycle progression genes for improved risk-stratification in a contemporary radical prostatectomy cohort," was presented on Thursday, February, 2, 2012 at the 2012 Genitourinary Cancers Symposium. The study concluded that the Prolaris score, which analyzes the expression level of 46 cell cycle progression genes, demonstrated significant and unique prognostic ability in a contemporary cohort of men who had undergone radical prostatectomy, and accurately predicted their elevated risk for prostate cancer recurrence. (Source: Medical News (via PRIMEZONE))

Thursday - NEWS TIPS

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 21:00:00 +0100

NEW ORLEANS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- NOTE ALL TIMES ARE CENTRAL. ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. CT/4 P.M. ET EACH DAY, WHICHEVER COMES FIRST. For more information Feb. 1-3, call Karen Astle, Bridgette McNeill, Julie Del Barto or Carrie Thacker at the New Orleans Convention Center at (504) 670-6010. Before or after these dates, call the Communications Office in Dallas at (214) 706-1396. For public inquiries call (800) AHA-USA1 (242-8721). (Source: Medical News (via PRIMEZONE))

Breast implant fears spark Brussels crackdown

FT.com - Drugs and Healthcare — Thu, 02 Feb 2012 20:47:02 +0100

European Commission is to toughen regulation of medical devices as a result of concerns over PIP products despite scientific review (Source: FT.com - Drugs and Healthcare)

Study Explores Role of Periprocedural Dabigatran in AF Ablation

Forbes.com Healthcare News — Thu, 02 Feb 2012 20:29:26 +0100

Updated with a comment from John Mandrola-- As dabigatran becomes more widely used in atrial fibrillation (AF) patients, electrophysiologists are now trying to figure out how to handle anticoagulation in patients taking dabigatran (Pradaxa) for whom AF ablation is planned. In a new study published in the Journal of the American College of Cardiology, Dhanunjaya Lakkireddy and colleagues report on a multicenter, observational study of 290 patients who underwent an AF ablation procedure. Half the patients were taking periprocedural dabigatran and half were matched controls taking warfarin. (Source: Forbes.com Healthcare News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

AstraZeneca to Cut 7,300 Jobs

WSJ.com: Health — Thu, 02 Feb 2012 20:23:16 +0100

AstraZeneca announced it will eliminate another 7,300 jobs, bringing its total cuts over the past five years to nearly 30,000. (Source: WSJ.com: Health)

Rural Health Clinic Billing Releases New White Paper: "Why Small Balance Billing Matters"

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 18:00:00 +0100

MORAINE, Ohio, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Rural Health Clinic Billing, the only billing company that is singularly focused on providing the leadership, expertise and technology necessary to enhance the success rate of small-balance billing collections at hospitals and clinics, has today released a white paper designed to help decision makers understand the paramount importance of small-balance billing collections. (Source: Medical News (via PRIMEZONE))

AstraZeneca unveils plans to cut 7,300 jobs

FT.com - Drugs and Healthcare — Thu, 02 Feb 2012 16:43:47 +0100

Anglo-Swedish drugs group, which pledged a $4.5bn share buy-back, reports 2% fall in revenues as competition from generics bites (Source: FT.com - Drugs and Healthcare)

The Supreme Court ruling: what's at stake for health care?

Forbes.com Healthcare News — Thu, 02 Feb 2012 16:21:03 +0100

(Source: Forbes.com Healthcare News)

More Evidence That Honey Can Treat Antibiotic Resistant Infections

Forbes.com Healthcare News — Thu, 02 Feb 2012 16:07:18 +0100

One of the more fascinating ways that medical researchers are looking in to fighting antibiotic resistant bacteria is through the use of Manuka honey. Last year, some research was published evidencing some effectiveness against MRSA. Now a team from the Cardiff School of Health Sciences has demonstrated the effectiveness of this honey against Streptococcus pyogenes, an antibiotic resistant bacteria that often infects wounds and can prevent skin grafts from forming. (Source: Forbes.com Healthcare News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Colibri Heart Valve Announces Issuance of Patent for New Method of Making Replacement Heart Valves

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 15:45:00 +0100

BROOMFIELD, CO, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, received an Issue Notification from the U.S. Patent and Trademark Office regarding the forthcoming granting of its U.S. Patent No. 8,109,995 titled, "Percutaneously Implantable Replacement Heart Valve Device And Method Of Making Same." The patent will issue on February 7, 2012 and is directed to a method of making a percutaneously implantable replacement transcatheter aortic heart valve using a folding technique covering both bovine and porcine pericardium. The associated patent application (12/228,192) has priority claims with content dating back to January 4, 2002. It is expected that the patent will provide Colibri with broad protection to prevent others from producing or ...

Mikulski Bill Would Speed Approval of New Drugs By FDA

Drugs.com - Pharma News — Thu, 02 Feb 2012 15:06:22 +0100

Mikulski bill would speed approval of new drugs by FDA [The Baltimore Sun] From Baltimore Sun (MD) (February 2, 2012) Feb. 02--WASHINGTON -- Drugs for chronic conditions such as Alzheimer's disease and diabetes would move through the Food and Drug... (Source: Drugs.com - Pharma News)

Vital's Vitrea(R) Enterprise Suite Ranks No. 1 in Advanced Visualization by KLAS Report: "2011 Best in KLAS Awards: Software & Services"

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:56:00 +0100

MINNEAPOLIS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Vital, a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, ranked number one for its Vitrea(r) Enterprise Suite (VES) software in the Advanced Visualization category of the "2011 Best in KLAS Awards: Software & Services" report released by the independent healthcare research firm. (Source: Medical News (via PRIMEZONE))

Integra LifeSciences to Present at Three Conferences in February

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:43:00 +0100

PLAINSBORO, N.J., Feb. 2, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month: (Source: Medical News (via PRIMEZONE))

AstraZeneca: short-term syndrome

FT.com - Drugs and Healthcare — Thu, 02 Feb 2012 14:41:03 +0100

If British drugmaker's share buy-backs continue while cutting back its workforce, investors should be worried (Source: FT.com - Drugs and Healthcare)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

IPC The Hospitalist Company, Inc. to Present at the UBS 22nd Annual Global Healthcare Services Conference

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:35:00 +0100

NORTH HOLLYWOOD, Calif., Feb. 2, 2012 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice company, announced today that Adam Singer, MD, Chairman and Chief Executive Officer, and Jeff Taylor, President and Chief Operating Officer, are scheduled to present on Tuesday, February 7, 2012 at the UBS 22nd Annual Global Healthcare Services Conference being held in New York, NY. (Source: Medical News (via PRIMEZONE))

Novel Findings for Molecular Profiling of Head and Neck Squamous Cell Carcinoma (HNSCC) Presented at the 2012 Multidisciplinary Head & Neck Cancer Symposium

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:30:00 +0100

This study retrospectively reviewed data aggregated from tumors molecularly profiled with Caris Target Now. (Source: Medical News (via PRIMEZONE))

Allergan Reports Fourth Quarter 2011 Operating Results

Drugs.com - Pharma News — Thu, 02 Feb 2012 14:12:21 +0100

Board of Directors Declares Fourth Quarter Dividend IRVINE, Calif.--(BUSINESS WIRE)--Feb 2, 2012 - Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended December 31, 2011. Allergan also announced that its Board... (Source: Drugs.com - Pharma News)

Merck Swings to Profit

WSJ.com: Health — Thu, 02 Feb 2012 14:07:23 +0100

Drug maker Merck swung to a profit amid fewer acquisition-related and restructuring charges, and it also reported a modest increase in revenue. (Source: WSJ.com: Health)

Symmetry Medical to Report Fourth Quarter 2011 Financial Results on February 23, 2012

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:00:00 +0100

WARSAW, Ind., Feb. 2, 2012 (GLOBE NEWSWIRE) -- Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including orthopedic implants, surgical instruments, and sterilization cases and trays, announced today that it will release fourth quarter 2011 financial results for the period ending December 31, 2011 before the market opens on Thursday, February 23, 2012. Symmetry Medical will host an accompanying conference call at 8:00 a.m. ET on Thursday, February 23, 2012. (Source: Medical News (via PRIMEZONE))

MedWorm Sponsor Message: Find the best January Sales in the UK.

Sickle Cell Anemia Stroke Prevention Efforts May Have Decreased Racial Disparities in Childhood Stroke Deaths

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:00:00 +0100

NEW ORLEANS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- The disparity in stroke-related deaths among black and white children dramatically narrowed after prevention strategies changed to include ultrasound screening and chronic blood transfusions for children with sickle cell anemia, according to research presented at the American Stroke Association's International Stroke Conference 2012. (Source: Medical News (via PRIMEZONE))

Rivaroxaban Has Less Risk of Brain Bleeding in Patients at High Risk for Stroke

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:00:00 +0100

NEW ORLEANS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Study Highlights: (Source: Medical News (via PRIMEZONE))

Erratic Heart Rhythm May Account for Some Unexplained Strokes

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:00:00 +0100

NEW ORLEANS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association's International Stroke Conference 2012. (Source: Medical News (via PRIMEZONE))

Anemia May More Than Triple Your Risks of Dying After a Stroke

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 14:00:00 +0100

NEW ORLEANS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Being anemic could more than triple your risk of dying within a year after having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012. (Source: Medical News (via PRIMEZONE))

MediSwipe Inc. Announces Letter of Intent to Acquire HIPAA Compliant Social Media Platform "ReachMeDaily.com"

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 13:56:00 +0100

LOS ANGELES, Feb. 2, 2012 (GLOBE NEWSWIRE) -- MediSwipe Inc. (www.MediSwipe.com) (OTCBB:MWIP.OB), a merchant payment solutions and financial products company for the medical health care industry, today announced a Letter of Intent to acquire the assets of ReachMeDaily.com, (www.ReachMeDaily.com) a Florida based social media and HIPAA compliant platform which connects families with seniors residing in nursing homes and assisted living facilities. The acquisition will be subject to satisfactory due diligence, completion of definitive agreements by both parties. (Source: Medical News (via PRIMEZONE))

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Ronnie Andrews Joins Life Technologies as President, Medical Sciences

HSMN NewsFeed — Thu, 02 Feb 2012 13:14:54 +0100

Leveraging 25-Plus Years Diagnostic Industry Experience, Andrews Will Shape Life Technologies Molecular Diagnostics Business CARLSBAD, Calif., Feb. 2, 2012 (HSMN NewsFeed) -- Life Technologies Corporation (NASDAQ: LIFE ) today announced that Ronnie An... Diagnostics, PersonnelLife Technologies (Source: HSMN NewsFeed)

Are We Sure Our Drugs Are Safe?

Drugs.com - Pharma News — Thu, 02 Feb 2012 13:02:58 +0100

[St. Joseph News-Press (MO)] From St. Joseph News-Press (MO) (February 1, 2012) (CNN) -- When Americans pick up their prescriptions from the pharmacy or reach for a prescription bottle from their medicine cabinet,... (Source: Drugs.com - Pharma News)

Novo Nordisk increased operating profit by 18% in 2011

Drugs.com - Pharma News — Thu, 02 Feb 2012 13:00:24 +0100

Sales growth of 9% driven by Victoza®, NovoRapid® and Levemir® * Sales increased by 11% in local currencies and by 9% in Danish kroner. o Sales of modern insulins... (Source: Drugs.com - Pharma News)

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis

HSMN NewsFeed — Thu, 02 Feb 2012 12:59:10 +0100

Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.--(Healthcare Sales & Marketing Network)-- Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl... Devices, InterventionalSpectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy (Source: HSMN NewsFeed)

Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results

Drugs.com - Pharma News — Thu, 02 Feb 2012 12:32:33 +0100

2011 Full-Year Non-GAAP EPS of $3.77, Excluding Certain Items; GAAP EPS of $2.02; Fourth-Quarter Non-GAAP EPS of $0.97, Excluding Certain Items; GAAP EPS of $0.49 2011 Full-Year Worldwide Sales Grew Four Percent to $48.0 Billion, Including Two... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

AstraZeneca?s New Restructuring Initiatives to Drive Productivity and Support Innovation

Drugs.com - Pharma News — Thu, 02 Feb 2012 12:24:02 +0100

Thursday, 2 February 2012 In conjunction with the publication of its full year 2011 results earlier today, AstraZeneca announced new restructuring initiatives designed to improve productivity and strengthen the company’s commercial, operations... (Source: Drugs.com - Pharma News)

Merge Healthcare Sets Fourth Quarter 2011 Earnings Call

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 12:23:00 +0100

CHICAGO, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Merge Healthcare (Nasdaq:MRGE), a leading provider of enterprise imaging and interoperability solutions, announced today the scheduling of its fourth quarter 2011 earnings call, which will be held at 8:30 AM ET on Thursday, February 16, 2012. (Source: Medical News (via PRIMEZONE))

Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis

Drugs.com - Pharma News — Thu, 02 Feb 2012 12:10:51 +0100

PLANEGG, GERMANY and MUNICH, GERMANY--(Marketwire - Feb 2, 2012) - Agennix AG (FRANKFURT: AGX) (XETRA: AGX) (ISIN DE000A1A6XX4) announced that, upon the recommendation of the study Data Safety Monitoring Board (DSMB), the Company has stopped further... (Source: Drugs.com - Pharma News)

American Heart Association's Go Red for Women(R) Movement and Elizabeth Banks Ask Women to Uncover the Truth About Heart Disease

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 12:00:00 +0100

DALLAS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Emmy-nominated actress Elizabeth Banks and the American Heart Association's Go Red For Women(r) movement are teaming up to share the truth that heart disease is the No. 1 killer of women. More women die of heart disease than all forms of cancer combined. Unfortunately, heart disease is often silent, hidden and misunderstood. That's why Go Red For Women is asking women to participate in the 9th Annual National Wear Red Day(r) on Friday, February 3, 2012, to make ending heart disease a reality. (Source: Medical News (via PRIMEZONE))

The American Heart Association's Go Red Por Tu Corazon and Chef Hamlet Garcia Raise Awareness Among Latinas About Heart Disease

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 12:00:00 +0100

DALLAS, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Heart disease continues to be the No. 1 killer of Latinas in the U.S. In fact, more women die of heart disease than all forms of cancer combined. Unfortunately, the killer isn't as easy to see, and may be difficult to identify for Latinas and their families. This Friday, Feb. 3 2012, is National Wear Red Day, a day meant to motivate Hispanic women in our communities to make healthy life choices for themselves and the ones they love to help stop heart disease. (Source: Medical News (via PRIMEZONE))

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Expansion of Research in Chiropractic Care is Ushering in New Era of Evidence-Based Therapies, Says American Specialty Health

Medical News (via PRIMEZONE) — Thu, 02 Feb 2012 11:00:00 +0100

SAN DIEGO, Feb. 2, 2012 (GLOBE NEWSWIRE) -- On the heels of new research showing that spinal manipulation and exercise are effective in relieving neck pain, American Specialty Health (ASH), one of the nation's leading providers of chiropractic health care benefits, said today that the expansion of research in chiropractic care is leading to big changes in the way chiropractic medicine is practiced and perceived in the United States. (Source: Medical News (via PRIMEZONE))

Bayer CO2 project among best ideas for the future

Bayer Company News — Thu, 02 Feb 2012 10:20:00 +0100

Pilot plant in Leverkusen is one of the “Selected Landmarks 2012” / Innovative process for producing plastics with carbon dioxide (Source: Bayer Company News)

EXCELLA GmbH API Plant Achieves SafeBridge Potent Compound Safety Certification

Pharmaceutical Online News — Thu, 02 Feb 2012 09:57:00 +0100

SAFEBRIDGE CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, has announced that Excella GmbH ("Excella") in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") at their chemical plant located in Feucht. (Source: Pharmaceutical Online News)

Smith & Nephew details plans to cut 770 jobs

FT.com - Drugs and Healthcare — Thu, 02 Feb 2012 09:38:09 +0100

Up to 7% of medical device maker's workforce to go in strategy to cut $150m and relieve pressure on margins (Source: FT.com - Drugs and Healthcare)

Open Innovation Possibilities To Be Explored By Fleming Europe In Amsterdam, 26 - 27 April 2012

Health News from Medical News Today — Thu, 02 Feb 2012 09:00:00 +0100

Major blockbuster drugs are facing the end of their era and big pharma companies are bracing for the effect in hopes that they will find a solution for their dwindling pipelines. Thus new opportunities and challenges are rising in the practice of open innovation and Fleming Europe will be there to explore them. According to a December 2011 report by The Economist, the most important blockbuster drugs will fall over the patent cliff by 2015. It will probably cause the need of a different industry model as new pricing pressures and increased regulatory requirements may occur... (Source: Health News from Medical News Today)

MedWorm Sponsor Message: Find the best January Sales in the UK.

News: AstraZeneca To Cut 7,300 Jobs

PharmaManufacturing.com — Thu, 02 Feb 2012 08:00:58 +0100

Drug firm AstraZeneca on Thursday said it would cut approximately 7,300 jobs as part of an ongoing initiative to reduce costs and drive innovation. (Source: PharmaManufacturing.com)

FTC blocks Omnicare acquisition of PharMerica

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

The Federal Trade Commission turned thumbs down on Omnicare?s attempted acquisition of competitor PharMerica. The agency filed suit in federal court to block the hostile takeover. (Source: Drug Topics - Pharmacy News)

AMCP objects to proposed reporting requirements for Part D

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

The Academy of Managed Care Pharmacy is not pleased with changes to the Medicare Part D reporting requirements proposed by the Centers for Medicare and Medicaid Services. (Source: Drug Topics - Pharmacy News)

Researchers warn of IV acetaminophen dosing errors

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

Researchers are warning pediatricians, pediatric hospitalists, and intensivists of the potential for intravenous acetaminophen dosing errors, especially in young patients under 2 years old. (Source: Drug Topics - Pharmacy News)

FDA approves tablets for the treatment of adults with type 2 diabetes

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

FDA has approved linagliptin/metformin hydrochloride (Jentadueto, Boehringer Ingelheim and Eli Lilly) tablets, a new tablet that provides a single-tablet treatment option, taken twice-daily, for adult patients who need to control their blood sugar. (Source: Drug Topics - Pharmacy News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Ivacaftor approved by FDA to treat rare form of cystic fibrosis

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

FDA approved ivacaftor (Kalydeco, Vertex Pharmaceuticals) for the treatment of a rare form of cystic fibrosis in patients aged 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator gene. (Source: Drug Topics - Pharmacy News)

Diabetes drug dapagliflozin fails to get approval from FDA

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

FDA declined approval of the diabetes drug dapagliflozin (Bristol-Myers Squibb and AstraZeneca), based on the recommendations of 1 of its advisory committees. (Source: Drug Topics - Pharmacy News)

Study: Dutasteride slows progression of prostate cancer in low-risk men

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

Dutasteride (Avodart, GlaxoSmithKline) delays the progression of prostate cancer in men with low-risk prostate cancer, according to a new study. (Source: Drug Topics - Pharmacy News)

Study: Emergency visits increase risk of infections for long-term care residents

Drug Topics - Pharmacy News — Thu, 02 Feb 2012 05:00:00 +0100

There was an increased risk of acute infection among long-term care residents who visited hospital emergency departments, according to a study published online January 23 in the Canadian Medical Association Journal. (Source: Drug Topics - Pharmacy News)

Positive phase III data on prostate cancer drug MDV3100 to be presented at conference

NeLM - News — Thu, 02 Feb 2012 05:00:00 +0100

Source: BioSpace Area: News Medivation, Inc. and Astellas Pharma Inc. have announced positive results on all efficacy endpoints from the phase III AFFIRM trial of the investigational drug MDV3100, an oral once daily androgen receptor signaling inhibitor, in men with prostate cancer previously treated with chemotherapy. Findings include the following: . Men taking MDV3100 lived for a median of 18.4 months, compared with 13.6 months for men taking placebo (p<0.0001; hazard ratio [HR] =0.631). . MDV3100 also met all secondary endpoints, including radiographic progression-free survival (8.3 vs. 2.9 months; p < 0.0001; HR=0.404), soft tissue response rate (28.9% vs. 3.8%; p < 0.0001) and time to PSA progression (8.3 vs. 3.0 months; p <...

MedWorm Sponsor Message: Find the best January Sales in the UK.

Device Makers, FDA Agree on Fees

WSJ.com: Health — Thu, 02 Feb 2012 01:43:35 +0100

Medical-device companies reached a tentative deal to pay the FDA $595 million over five years to increase the number of federal workers who approve devices and get new devices on the market faster. (Source: WSJ.com: Health)

Pfizer Recalls Some Birth-Control Pills

WSJ.com: Health — Thu, 02 Feb 2012 01:30:09 +0100

Pfizer recalled about a million packs of birth-control pills that weren't packaged correctly and raised the risk of unplanned pregnancies. (Source: WSJ.com: Health)

Repealing the CLASS Act

Forbes.com Healthcare News — Thu, 02 Feb 2012 00:14:16 +0100

The first part of the health reform law to fall was not struck down by the Supreme Court, blocked by state governments, or defunded by Congress – it was struck down by the Obama Administration itself, which stated that the program could not be implemented as passed, and therefore would simply be ignored. (Source: Forbes.com Healthcare News)

Evonik Pharma Polymers-Functional Pharmaceutical Excipients and Advanced Formulation Solutions

Pharmaceutical Technology — Thu, 02 Feb 2012 00:00:00 +0100

With its Pharma Polymers product line, Evonik is a major provider of functional pharmaceutical excipients and advanced formulation solutions. (Source: Pharmaceutical Technology)

AstraZeneca job cuts more severe than feared

Pharmaceutical Technology — Thu, 02 Feb 2012 00:00:00 +0100

Job cuts at Anglo-Swedish pharmaceutical firm AstraZeneca (AZ) are to be worse than feared, following an announcement made by the company amid rumours previously reported in the Sunday Times. (Source: Pharmaceutical Technology)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Less is more: why rare disease funding is on the up

Pharmaceutical Technology — Thu, 02 Feb 2012 00:00:00 +0100

Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National Organization for Rare Disorders (NORD) and Dr Steve Groft of the Off… (Source: Pharmaceutical Technology)

Generic Liptor causes Pfizer profit slump

Pharmaceutical Technology — Thu, 02 Feb 2012 00:00:00 +0100

Pharmaceutical major Pfizer has announced a 50% slump in net income for Q4 2011 as the company suffers at the hands of generic versions of its cholesterol blockbuster Lipitor. (Source: Pharmaceutical Technology)

Scavenging Technologies from Johnson Matthey-Product Purification and Recovery of Precious and Base Metals

Pharmaceutical Technology — Thu, 02 Feb 2012 00:00:00 +0100

Scavenging Technologies, a business unit of Johnson Matthey dedicated to product purification and recovery of precious and base metals, offers an extensive range of pure, fast and effective metal scavengers for use in the pharmaceutical industry. (Source: Pharmaceutical Technology)

Less is more: why rare disease funding is on the up

Drug Development Technology — Thu, 02 Feb 2012 00:00:00 +0100

MDV3100 shows efficacy against prostate cancer

Drug Development Technology — Thu, 02 Feb 2012 00:00:00 +0100

Medivation and Astellas Pharma have announced the positive results from the Phase 3 AFFIRM trial of the investigational drug MDV3100 in men with prostate cancer previously treated with chemotherapy. (Source: Drug Development Technology)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Novartis Glivec wins extended FDA approval for three-year treatment

Drug Development Technology — Thu, 02 Feb 2012 00:00:00 +0100

The Novartis Glivec (imatinib) label has received an extended approval by the US Food and Drug Administration (FDA) to recommend 36 months of treatment for adult patients with KIT (CD117)-positive gastrointestinal stromal tumours (GIST). (Source: Drug Development Technology)

Pfizer recalls 1m packets of birth control pills

FT.com - Drugs and Healthcare — Wed, 01 Feb 2012 23:50:49 +0100

An internal investigation found faults in the packaging of some pills that could potentially lead to unwanted pregnancies (Source: FT.com - Drugs and Healthcare)

Medical-Device Firms in Accord With FDA on User Fees

WSJ.com: Health — Wed, 01 Feb 2012 22:57:49 +0100

Tranzyme Pharma lands $9M in debt financing

bizjournals.com Health Care:Physician Practices headlines — Wed, 01 Feb 2012 22:29:21 +0100

Tranzyme Pharma (Nasdaq:TZYM), a drug development company in Research Triangle Park, on Wednesday announced that it has landed an additional $9.3 million in debt financing from Oxford Finance LLC and Horizon Technology Finance Corp. (Nasdaq:HRZN). Vipin K. Garg, president and CEO of Tranzyme, says the money will help Tranzyme take one of its drugs to a new drug application later this year. Because of research and development costs, Tranzyme typically reports net operating losses. Through the first nine months of last year, it reported $13... (Source: bizjournals.com Health Care:Physician Practices headlines)

Vascular Solutions Reports Fourth Quarter Results

Medical News (via PRIMEZONE) — Wed, 01 Feb 2012 21:10:00 +0100

MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today reported financial results for the fourth quarter and full year ended December 31, 2011. For the quarter, net revenue was $22.1 million, an increase of 6% from the $20.9 million in the fourth quarter of 2010. U.S. revenue increased 5% to $18.4 million, while international revenue grew 11% to $3.7 million. For the year, net revenue increased by 15% to a record $90.0 million, representing the eighth consecutive year of greater than 10% revenue growth for Vascular Solutions. (Source: Medical News (via PRIMEZONE))

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters

Medical News (via PRIMEZONE) — Wed, 01 Feb 2012 21:05:00 +0100

MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST catheter, which is manufactured and marketed by VNUS Medical Technologies, Inc. division of Covidien, is widely used for performing endovenous therapy for the treatment of varicose veins. Vascular Solutions' reprocessing service is designed to help physicians reduce medical waste and lower their costs. (Source: Medical News (via PRIMEZONE))

French Report Blames Implant Maker, Officials

WSJ.com: Health — Wed, 01 Feb 2012 21:02:58 +0100

The French company at the heart of a scandal over faulty breast implants repeatedly misled and tricked authorities, who themselves neglected warning signs, a French government report said. (Source: WSJ.com: Health)

Roche Upbeat as Profit Rises

WSJ.com: Health — Wed, 01 Feb 2012 19:38:07 +0100

Swiss pharmaceutical company Roche issued an upbeat outlook for 2012 after reporting a rise in full-year net profit due to tight cost controls and despite a drop in annual sales. (Source: WSJ.com: Health)

Independent Survey of US Oncologists by National Analysts Worldwide Finds Drug Shortages and Escalating Costs Result in Grave Health Consequences

Drugs.com - Pharma News — Wed, 01 Feb 2012 19:02:36 +0100

Nearly half of surveyed oncologists saw tumors recur and patients die sooner due to drug shortages; 73 percent substituted sub-optimal care due to patient inability to afford drug co-payments PHILADELPHIA--(BUSINESS WIRE)--Feb 1, 2012 - A... (Source: Drugs.com - Pharma News)

Dendreon Names A New CEO, But Will It Be Enough?

Forbes.com Healthcare News — Wed, 01 Feb 2012 19:02:11 +0100

After a year filled with setbacks and mounting investor anger, Dendreon has replaced Mitchell Gold as ceo with John Johnson, a recently appointed Dendreon board member who has a long track record of working in oncology for big pharma - notably, Eli Lilly and Johnson & Johnson. The move signals a belated recognition that the embattled company needs more experienced management if its Provenge vaccine for prostate cancer is to become a blockbuster. (Source: Forbes.com Healthcare News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Pfizer Recalls Birth-Control Pills

WSJ.com: Health — Wed, 01 Feb 2012 18:52:30 +0100

Pfizer is recalling two types of birth-control pills because the packages might not contain the right mix of pills, raising the risk of an unplanned pregnancy. (Source: WSJ.com: Health)

Meta-Analysis Confirms Benefits Of Statins In Women

Forbes.com Healthcare News — Wed, 01 Feb 2012 17:59:12 +0100

Although clinical trials have consistently found a beneficial effects for statins, some critics have questioned the strength of the evidence in women, who are often under-represented in clinical trials. A large new meta-analysis published in the Journal of the American College of Cardiology provides the best evidence yet that the relative reductions in events observed in men also occur in women, but doesn't provide evidence about the absolute risk benefit in women. (Source: Forbes.com Healthcare News)

Which Pharma company is leading the charge in Productive Innovation for 2012?

Drugs.com - Pharma News — Wed, 01 Feb 2012 17:46:09 +0100

IDEA Pharma has launched the second annual Productive Innovation Index (PII), ranking 21 global pharmaceutical companies for their ability to add value to, and derive value from, molecules in pre-launch. The word “innovation” is often... (Source: Drugs.com - Pharma News)

Dendreon Names New CEO

WSJ.com: Health — Wed, 01 Feb 2012 17:38:47 +0100

Dendreon named John H. Johnson, the CEO of Savient Pharmaceuticals, to succeed Mitchell H. Gold as president and CEO. (Source: WSJ.com: Health)

NHS tests John Lewis-style management

FT.com - Drugs and Healthcare — Wed, 01 Feb 2012 17:25:00 +0100

A Cambridgeshire hospital is testing the politically toxic issue of private sector involvement (Source: FT.com - Drugs and Healthcare)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

SCHOTT Appoints Vice President of Global Syringe Business

Pharmaceutical Technology — Wed, 01 Feb 2012 16:36:47 +0100

SCHOTT has appointed Christophe Muguet as vice president of its global syringe business. He leads this area's business activities as part of SCHOTT Pharmaceutical Packaging from the offices in St Gallen, Switzerland. (Source: Pharmaceutical Technology)

Pfizer EVP Among Obama 'Top Money Bundlers'

Drugs.com - Pharma News — Wed, 01 Feb 2012 14:51:18 +0100

Obama releases list of top money 'bundlers' From Associated Press (February 1, 2012) WASHINGTON -- President Barack Obama's re-election campaign identified its top fundraisers on Tuesday, including 61 people who each raised at least half a million... (Source: Drugs.com - Pharma News)

D&R Acquires LATHIAN to Create Leading Multichannel Marketing Agency

Drugs.com - Pharma News — Wed, 01 Feb 2012 14:50:23 +0100

New Combined Entity Delivers Strategic Multichannel Marketing Services Under One Roof for Pharmaceutical Companies to Increase Brand Performance at Any Stage of their Product Lifecycle SHREWSBURY, N.J. & LAKE FOREST, Calif.--(BUSINESS... (Source: Drugs.com - Pharma News)

Study: E-Prescribing Shown to Improve Outcomes and Save U.S. Healthcare System Billions of Dollars

Drugs.com - Pharma News — Wed, 01 Feb 2012 14:25:25 +0100

ARLINGTON, VA -- (MARKET WIRE) -- 02/01/12 -- Surescripts, the nation's e-prescription network, today announced study findings from de-identified data that link e-prescribing to a significant increase in first-fill medication adherence. Poor... (Source: Drugs.com - Pharma News)